Results for tag: "Nplate"

Nplate is a hematological drug used to treat low platelet counts in adults with chronic immune thrombocytopenia (ITP). It is a recombinant form of thrombopoietin, a naturally occurring hormone that stimulates the production of platelets. Nplate works by stimulating the bone marrow to produce more platelets, which helps to reduce the risk of bleeding. It is administered as a subcutaneous injection once a week. Nplate is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2008. It is the only FDA-approved thrombopoietin receptor agonist for the treatment of ITP. It has been shown to be effective in increasing platelet counts and reducing the risk of bleeding in patients with ITP. Nplate is marketed by several companies, including Amgen, Novartis, and Pfizer. It is available in the United States, Canada, Europe, and other countries. Show Less Read more